Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now lists revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check8 days agoChange Detected- Added sponsor/institution references and a 'Helpful Links Provided by' section in the page footer (Moffitt Cancer Center Clinical Trials website, H. Lee Moffitt Cancer Center and Research Institute).SummaryDifference0.1%

- Check15 days agoChange DetectedRemoved sponsor/affiliation blocks for Moffitt Cancer Center and the associated 'Helpful Links' section.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1, likely a template/UI adjustment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe update timestamp label on the Study Details page changed from 'Last Update Posted (Estimated)' to 'Last Update Posted', a minor presentation change to study metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.